AJNR Am J Neuroradiol

1. SALL C, Salomonsson T, Grubor I, Saenz Sarda X, et al
   Mapping fluid-suppressed diffusivity in brain tumors.
   AJNR Am J Neuroradiol. 2026 Jul 24:ajnr.A9545. doi: 10.3174/ajnr.A9545.
   

   >> Share

   
   

   
   Int J Cancer

2. WANG H, Li J, Cao L, Zhang Y, et al
   Efficacy and Safety Profile of a Rituximab, Methotrexate, and Thiotepa-Based Regimen in Newly Diagnosed Primary CNS Lymphoma.
   Int J Cancer. 2026 Apr 18. doi: 10.1002/ijc.70507.
   

   >> Share

   
   

   
   Int J Radiat Oncol Biol Phys

3. PERLOW HK, Dawson EL, Sun Y, Yu J, et al
   Early Integrated Neuropsychological Care for Patients with Brain Metastases: A Randomized Controlled Trial (ATHENA Trial).
   Int J Radiat Oncol Biol Phys. 2026 Jul 18:S0360-3016(26)04025.
   

   >> Share

   
   

   
   J Clin Oncol

4. LIANG B, Weil M
   Corticosteroids in Glioblastoma Management: A Reconsideration of a 65-Year Practice.
   J Clin Oncol. 2026 Jul 22:JCO2600191. doi: 10.1200/JCO-26-00191.
   

   >> Share

   
   

   
   J Neurooncol

5. KINGER S, Sedor G, Buss EJ, Giannaris E, et al
   Frameless stereotactic radiosurgery in the management of brain metastases: long-term oncologic and toxicity outcomes.
   J Neurooncol. 2026;179:4.
   

   >> Share

   
   
6. MAATTA J, Laajava J, Niemela M, Korja M, et al
   Declining age-adjusted surgical incidence of intracranial meningiomas: a 19-year retrospective analysis from an academic hospital.
   J Neurooncol. 2026;179:6.
   

   >> Share

   
   
7. XING J, Feinaj A, Ritter Z, Clarke K, et al
   Spatial distribution and prognostic significance of hemorrhagic imaging features in brain metastases from metastatic renal cell carcinoma.
   J Neurooncol. 2026;179:5.
   

   >> Share

   
   
8. ZHU Y, Yu S, Du B, Yao N, et al
   The persistent benefit of chemotherapy in elderly lung adenocarcinoma patients with brain metastases in the immunotherapy era.
   J Neurooncol. 2026;179:7.
   

   >> Share

   
   
9. MARCHAL J, Ybert L, Ducloie M, Geffrelot J, et al
   The threefold value of surgery in previously irradiated brain metastases.
   J Neurooncol. 2026;179:8.
   

   >> Share

   
   
10. WOJTON-DZIEWONSKA D, Skora T, Aniol J, Popow-Gierba A, et al
    Survival, late toxicity and ability to return to work after proton radiotherapy for low-grade gliomas.
    J Neurooncol. 2026;179:9.
    

    >> Share

    
    
11. MUSTAFA MA, Hannan CJ, Amoo M, Sokan J, et al
    Derivation of a data-driven follow-up protocol for resected skull base meningiomas: a Bayesian analysis.
    J Neurooncol. 2026;179:11.
    

    >> Share

    
    
12. DREWES NB, Koutah L, Jain R, Carnduff J, et al
    Extent of resection and survival in IDH-wildtype glioblastoma: interaction with MGMT status and chemoradiation.
    J Neurooncol. 2026;179:10.
    

    >> Share

    
    
13. CARRIERE PP, Haisraely O, Aaroe A, Ahmed K, et al
    Long-term outcomes in IDH-wildtype (IDH-wt) gliomas with historical WHO grade 2 and 3 histology.
    J Neurooncol. 2026;179:12.
    

    >> Share

    
    
14. SANDERSON E, Drummond K, Dowling A, Bennett I, et al
    Salvage therapies for recurrent grade 4 IDH-wildtype glioma: a BRAIN Registry analysis of real-world treatment patterns.
    J Neurooncol. 2026;179:13.
    

    >> Share

    
    
15. ZHU JW, Fernandes I, Lopes JB, Moravan V, et al
    Clinicopathological factors associated with brain metastases development among breast cancer patients receiving neoadjuvant chemotherapy.
    J Neurooncol. 2026;179:14.
    

    >> Share

    
    

    
    J Neuropathol Exp Neurol

16. DE MENDONCA FERNANDES GM, Wu KC, Palmer J, Carrau R, et al
    NICO Myriad Automated Preservation System improves meningioma sample quality for molecular pathology assays.
    J Neuropathol Exp Neurol. 2026 Jul 20:nlag030. doi: 10.1093.
    

    >> Share

    
    

    
    J Neurosurg

17. FABIANO AJ
    Letter to the Editor. The utility of biopsy prior to craniotomy in high-grade glioma.
    J Neurosurg. 2026 Jul 24:1-2. doi: 10.3171/2026.2.JNS26270.
    

    >> Share

    
    

    
    Neuro Oncol

18. FILIBERTI S, Tavani C, Somenza E, Tassone N, et al
    A PTX3/TLR4 axis sustains SHH-Medulloblastoma growth and defines a new therapeutic vulnerability.
    Neuro Oncol. 2026 Jul 23:noag167. doi: 10.1093.
    

    >> Share

    
    
19. LAU BC, Ajaero DP, Hoff BA, Pearson A, et al
    Early increase in apparent diffusion coefficient predicts favorable response to Dordaviprone (ONC201) therapy in H3K27M-mutant diffuse midline glioma.
    Neuro Oncol. 2026 Jul 21:noag164. doi: 10.1093.
    

    >> Share

    
    
20. HAN S, Kim Y, Kim S, Lee C, et al
    Programmable microfluidic modeling of the glioblastoma immune microenvironment recapitulates temporally regulated tumor-immune signaling.
    Neuro Oncol. 2026 Jul 21:noag151. doi: 10.1093.
    

    >> Share

    
    
21. KINSLOW CJ, Schiff D
    Mature Results from EORTC 22033: Implications of Inferior Results with Monotherapy for Grade 2 Gliomas.
    Neuro Oncol. 2026 Jul 20:noag162. doi: 10.1093.
    

    >> Share

    
    

    
    PLoS One

22. YANG J, Kollings J, Idnani E, Wilson DR, et al
    Engineering of episomal plasmid structure to enhance non-viral Poly(beta-amino ester) nanoparticle gene delivery to liver and brain cancer cells.
    PLoS One. 2026;21:e0352468.
    

    >> Share

    
    

    
    Radiology

23. HOCH MR, Breza VR, Miller GW, Price RJ, et al
    Quantitative Susceptibility Mapping Shows Size-dependent Focused Ultrasound-mediated Therapeutic Delivery to Naive Brain and Gliomas in Mice.
    Radiology. 2026;320:e251005.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share